Merit Medical Systems, Inc. (MMSI - Free Report) reported second-quarter 2019 adjusted earnings per share (EPS) of 42 cents, lagging the Zacks Consensus Estimate of 50 cents by 16%. The bottom line also deteriorated 2.3% from the year-ago quarter.
This Utah-based provider of peripheral and cardiac intervention products reported worldwide revenues of $255.5 million, up 13.7% from the year-ago quarter. On a comparable constant-currency basis, the metric improved 9.6% year over year. However, the top line missed the Zacks Consensus Estimate of $258.9 million by 1.3%.
The Cardiovascular unit reported second-quarter revenues of $246.7 million, up 14% year over year. The upside can be attributed to year-over-year increase of 11.9% in the segment’s Stand-alone devices to $103.5 million. Further, revenues from Catheters improved 15.2% to $45.3 million. The same for embolization devices rose 10.1% to $14 million.
Moreover, revenues at the CRM/EP unit increased 3% to $13.9 million. Further, revenues from Custom kits and procedure trays unit, under the Cardiovascular segment, rose 1% to $34.3 million. Inflation devices revenues remained flat on a year-over-year basis at $24.3 million.
Revenues from the Endoscopy devices totaled $8.9 million, up 5.3% year over year.